与微脉冲激光相结合的康伯塞普的临床疗效在患有多重性胆道性血管病变的患者中
Qingyan Liu1, Yao Lu2, Shuo Sun3
1Anhui NO.2 Provincial People's hospital, Hefei, China.
Lasers in medical science
|September 21, 2025
概括
将conbercept与微脉冲激光 (MPL) 结合起来,显著改善了多冠状血管病 (PCV) 的结果. 与单独使用conbercept相比,这种组合疗法提供了更好的视觉敏度和视网膜结构改善.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 血管生物学 血管生物学
背景情况:
- 聚冠状血管病变 (PCV) 是视力丧失的重要原因之一.
- 目前的治疗方法旨在控制新血管和流体泄漏.
- 评估新型治疗组合对于改善PCV管理至关重要.
研究的目的:
- 评估conbercept与微脉冲激光 (MPL) 结合用于PCV的临床疗效.
- 为了比较这种组合治疗与conbercept单一治疗.
- 调查细胞因子水平与治疗结果之间的相关性.
主要方法:
- 一项前性随机对照试验,对52名PCV患者进行.
- 组:康伯塞普单一治疗与康伯塞普+MPL.
- 在三个月内每月评估最佳校正的视敏度 (BCVA),中央黄斑厚度 (CMT) 和总黄斑体积 (TMV).
- 水性幽默细胞因子的分析 (VEGF-A,IL-5,MCP-1,Ang-2).
主要成果:
- 两组都显示出改善的BCVA和减少的CMT/TMV.
- 康贝cept + MPL 组表现出明显更大的改善 (P < 0.05).
- 降低的VEGF-A和MCP-1水平与BCVA,CMT和TMV的改善正相关 (P <0.05).
结论:
- 与MPL治疗相结合的Conbercept比对PCV的Conbercept单一治疗更有效.
- 改变VEGF-A和MCP-1可以预测视觉和形态的改善.
- 这种组合为PCV提供了有前途的治疗策略.
相关概念视频
Open Angle Glaucoma: Treatment
963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
963
Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K


